If you are not sure if the website you would like to visit is secure, you can verify it here. Enter the website address of the page and see parts of its content and the thumbnail images on this site. None (if any) dangerous scripts on the referenced page will be executed. Additionally, if the selected site contains subpages, you can verify it (review) in batches containing 5 pages.

site address: cancertherapyadvisor.com redirected to: www.cancertherapyadvisor.com

site title: Cancer Articles, News & Research Info | Treatment & Drug Trials - Cancer Therapy Advisor

Our opinion:

GREEN status (no comments) - no comments
After content analysis of this website we propose the following hashtags:


Proceed to the page?Powered by: Very Tiny URL Shortener at https://vturl.net VeryTinyURL

Meta tags:
description=Latest cancer articles, treatment info, research news and more for oncologists and other medical professionals. Updated cancer news delivered to your inbox.;

Headings (most frequently used words):

in, cancer, for, news, and, more, featured, latest, cell, may, biopsies, liquid, cells, circulating, tumor, tool, new, pembrolizumab, prognostic, therapy, fact, leukemia, calcium, with, small, myeloma, of, fda, prostate, trial, breast, lung, non, multiple, inhibition, effective, checkpoint, melanoma, acute, treatment, sheet, metastatic, car, aspartame, renal, axitinib, additional, carcinoma, patients, focus, deaths, clinical, related, after, stage, er, telotristat, combination, explore, the, myeloid, chronic, ponatinib, carcinoid, diarrhea, early, syndrome, olaparib, use, approval, l1, pd, monotherapy, atezolizumab, ipilimumab, compared, survival, overall, lymphoblastic, statin, prolongs, decrease, ovarian, mortality, ctcs, tablets, risk, telomere, tki, survivors, second, among, rates, prescription, opioid, be, discontinuation, feasible, safe, cml, higher, liver, radiotherapy, individualized, shorter, provide, length, listings, medical, haymarket, other, center, user, resources, newsletters, free, up, sign, articles, advisor, drug, predicts, regimen, issue, digital, sheets, board, advisory, editorial, features, top, results, promising, yields, vhl, vaccine, approved, negative, sbla, outcomes, disparities, racial, efficacy, grants, priority, review, to, brentuximab, cutaneous, demonstrates, lymphoma, vitamin, sequencing, effectively, guide, enasidenib, well, aml, tolerated, safety, diagnosis, triple, job, pfs, prolong, ipatasertib, besponsa, benefit, perspective, evolutionary, an, regimens, looking, ask, nsclc, genetic, mutations, determine, likelihood, metastasis, sarcoma, treating, experts, at, websites,

Text of the page (most frequently used words):
cancer (81), for (47), and (46), the (24), news (22), #therapy (22), advisor (20), cell (20), #regimens (18), more (17), may (17), treatment (16), with (16), #patients (15), #drugs (14), #islands (13), new (11), myeloma (11), drug (10), #clinical (10), prostate (10), center (10), resource (10), featured (10), latest (10), multiple (10), leukemia (9), effective (9), #pembrolizumab (9), breast (9), biopsies (9), liquid (9), lung (8), fda (7), cancers (7), calcium (7), that (7), tumor (6), prognostic (6), oncology (6), small (6), #survival (6), acute (6), melanoma (6), circulating (6), cells (6), saint (6), olaparib (6), tablets (6), ovarian (6), tool (6), trial (5), non (5), car (5), inhibition (5), checkpoint (5), about (5), decrease (5), lymphoblastic (5), approval (5), ipilimumab (5), metastatic (5), renal (5), among (5), additional (5), stage (4), diarrhea (4), mutations (4), fact (4), phd (4), information (4), chronic (4), axitinib (4), free (4), endocrine (4), carcinoma (4), early (4), aspartame (4), use (4), prolongs (4), island (4), risk (4), guinea (4), metastasis (4), other (4), compared (4), overall (4), atezolizumab (4), monotherapy (4), telotristat (4), does (3), side (3), statin (3), safe (3), adjuvant (3), extended (3), republic (3), determine (3), job (3), incidence (3), sarcoma (3), access (3), effect (3), experts (3), united (3), ponatinib (3), likelihood (3), haymarket (3), rcc (3), trials (3), french (3), sheet (3), have (3), unlikely (3), myeloid (3), diagnosis (3), cml (3), dose (3), vitamin (3), mortality (3), nsclc (3), hematologic (3), skin (3), prior (3), our (3), rss (3), lymphoma (3), vaccine (3), board (3), subscribe (3), besponsa (3), disease (3), medical (3), approved (3), genetic (3), this (3), prolong (3), care (3), racial (2), failure (2), urologic (2), head (2), ewald (2), approaches (2), informed (2), evolutionarily (2), safer (2), possibly (2), augment (2), neck (2), imply (2), netherlands (2), combination (2), who (2), explore (2), disparities (2), one (2), least (2), received (2), outcomes (2), based (2), benefit (2), triplet (2), read (2), than (2), deaths (2), articles (2), related (2), after (2), work (2), gynecologic (2), represents (2), rather (2), carcinoid (2), appropriate (2), selecting (2), though (2), perspective (2), full (2), listings (2), view (2), efficacious (2), here (2), syndrome (2), digital (2), get (2), profile (2), issue (2), andrea (2), blevins (2), primeau (2), relatively (2), mba (2), congo (2), correct (2), can (2), option (2), also (2), approach (2), enthusiasm (2), progress (2), never (2), would (2), alone (2), left (2), gastrointestinal (2), brain (2), find (2), might (2), difficult (2), bone (2), tests (2), these (2), treatments (2), monitoring (2), successful (2), prove (2), could (2), while (2), focus (2), evolutionary (2), redirect (2), efficacy (2), higher (2), british (2), mcknight (2), decisions (2), vhl (2), predicts (2), length (2), montenegro (2), telomere (2), shorter (2), survivors (2), plus (2), rates (2), prescription (2), opioid (2), sign (2), tools (2), provide (2), help (2), phase (2), between (2), practice (2), facebook (2), twitter (2), resources (2), ctcs (2), advisory (2), many (2), newsletters (2), virgin (2), management (2), korea (2), negative (2), exon (2), samoa (2), ipatasertib (2), not (2), liver (2), radiotherapy (2), individualized (2), pfs (2), triple (2), top (2), all (2), cisplatin (2), media (2), mark, multimedia, shore, regimen, conferences, neal, socinski, headlines, supportive, feeds, app, cme, google, cases, register, print, submit, log, jobs, linkedin, sheets, page, click, complete, profiles, mario, sznol, through, flip, safety, issues, listing, pediatric, fluorouracil, gyn, neoadjuvant, epirubicin, capecitabine, popular, emailed, recent, esophageal, dendritic, second, tki, discontinuation, feasible, approves, neratinib, research, progression, asct, pancreatic, jeffrey, general, lymphocytic, bladder, rare, study, 6mhp, advanced, yields, post, promising, results, surrogate, infection, poses, serious, threat, facs, cunningham, but, how, best, treat, ask, treating, paul, highly, swain, holly, optimal, individualizing, still, being, determined, increased, insurance, diversification, workforce, jenks, susan, close, gaps, interviewed, line, likely, receptor, over, 200, openings, throughout, discuss, looking, biomarker, testing, epidermal, growth, factor, first, deletions, features, l858r, substitution, important, when, considering, hughes, debra, supplementation, reduce, farma, demonstrates, sequencing, effectively, guide, grants, priority, review, brentuximab, sbla, cutaneous, editorial, kistler, burtness, ann, barbara, cohen, steven, crawford, david, isabel, facp, dizon, don, andrew, pharmd, chemotherapy, leah, cause, harm, despite, controversy, studies, found, significant, association, lawrence, consumption, different, rph, types, solid, malignancies, evidence, mixed, relationship, intake, colorectal, enasidenib, well, tolerated, aml, available, copyright, interactions, africa, jan, mayen, suriname, sudan, sri, lanka, spain, south, somalia, swaziland, solomon, slovenia, slovakia, singapore, sierra, leone, seychelles, serbia, svalbard, sweden, saudi, tonga, tuvalu, turks, caicos, turkmenistan, turkey, tunisia, trinidad, tobago, tokelau, switzerland, togo, timor, leste, thailand, tanzania, tajikistan, taiwan, syria, senegal, arabia, ukraine, oman, pitcairn, philippines, peru, paraguay, papua, panama, palau, pakistan, norway, portugal, northern, mariana, north, norfolk, niue, nigeria, niger, nicaragua, poland, rico, sao, martin, tome, principe, san, marino, vincent, grenadines, pierre, miquelon, lucia, puerto, kitts, nevis, helena, rwanda, russia, romania, reunion, qatar, uganda, emirates, caledonia, senior, urology, pulmonology, psychiatry, nurse, neurology, mycme, mpr, bag, living, cardiology, long, term, infectious, endocrinology, pain, websites, choices, rheumatology, policy, staff, any, inc, rights, reserved, material, published, broadcast, rewritten, redistributed, form, privacy, without, authorization, your, website, constitutes, acceptance, terms, conditions, sitemap, contact, arab, western, making, right, their, return, zimbabwe, zambia, yugoslavia, yemen, wallis, practical, futuna, vietnam, venezuela, vatican, city, vanuatu, uzbekistan, uruguay, assist, base, advertise, emerging, user, useful, links, submissions, mission, focused, reflective, current, principles, knowledge, will, inform, cancertherapyadvisor, com, online, offers, healthcare, professionals, comprehensive, zealand, antilles, herb, faso, african, cayman, cape, verde, cameroon, cambodia, burundi, burkina, bulgaria, chad, brunei, darussalam, indian, ocean, territory, brazil, bouvet, botswana, central, chile, herzegovina, ivoire, dominica, djibouti, denmark, czech, cyprus, cuba, croatia, côte, costa, china, rica, cook, drc, comoros, colombia, cocos, keeling, christmas, bosnia, bolivia, ecuador, update, albania, afghanistan, canada, kingdom, states, weekly, highlights, daily, 2017, american, elusive, explanation, low, fat, diet, mantle, evaluating, landscape, algeria, andorra, bhutan, bahamas, bermuda, benin, belize, belgium, belarus, barbados, bangladesh, bahrain, azerbaijan, angola, austria, australia, aruba, armenia, argentina, antigua, barbuda, antarctica, anguilla, dominican, egypt, nepal, lebanon, macedonia, macao, luxembourg, lithuania, liechtenstein, libya, liberia, lesotho, latvia, malawi, laos, kyrgyzstan, kuwait, kiribati, kenya, kazakhstan, jordan, japan, madagascar, malaysia, italy, moldova, nauru, namibia, myanmar, mozambique, morocco, montserrat, mongolia, monaco, micronesia, maldives, mexico, mayotte, mauritius, mauritania, martinique, marshall, malta, mali, jamaica, israel, salvador, finland, georgia, gambia, gabon, southern, territories, polynesia, guiana, france, fiji, ghana, faroe, falkland, malvinas, ethiopia, estonia, eritrea, equatorial, germany, gibraltar, ireland, honduras, iraq, iran, indonesia, india, iceland, hungary, hong, kong, heard, greece, mcdonald, haiti, guyana, bissau, guatemala, guam, guadeloupe, grenada, greenland, info,
Thumbnail images (randomly selected): * Images may be subject to copyright.GREEN status (no comments)
  • Ipatasertib May Prolong P...
  • Liquid Biopsies for Circu...
  • Second TKI Discontinuatio...
  • In Focus: Ponatinib for C...
  • Individualized Radiothera...
  • Calcium and Cancer
  • Additional FDA Approval f...
  • Atezolizumab Monotherapy ...
  • Higher Opioid Prescriptio...
  • Checkpoint Inhibition in ...
  • Statin-use May Decrease M...
  • Shorter Telomere Length P...
  • Pembrolizumab Prolongs Ov...
  • Melanoma Vaccine Trial Yi...
  • Checkpoint Inhibition in ...
  • CAR T Cell Therapy for Ac...
  • Liquid Biopsies for Circu...
  • In Focus: Axitinib for Me...
  • Telotristat for Diarrhea ...
  • Calcium and Cancer
  • Aspartame and Cancer

The site also has references to the 1 subdomain(s)

  jobs.cancertherapyadvisor.com  Verify


Top 50 hastags from of all verified websites.

Supplementary Information (add-on for SEO geeks)*- See more on header.verify-www.com

Header

HTTP/1.1 301 Moved Permanently
Date Sat, 19 Aug 2017 05:35:44 GMT
Server Apache/2.4.7 (Ubuntu)
Location htt???/www.cancertherapyadvisor.com/
Content-Length 333
Content-Type text/html; charset=iso-8859-1
HTTP/1.1 200 OK
Cache-Control private
Cache-control no-cache="set-cookie"
Content-Encoding gzip
Content-Type text/html; charset=utf-8
Date Sat, 19 Aug 2017 05:45:02 GMT
Powered-By New VM-Web1
Server Microsoft-IIS/8.5
Set-Cookie ASP.NET_SessionId=uhbeeswnpabmj21nqpn43njq; path=/; HttpOnly
Set-Cookie CustomModalRegistrationDelay18=true; expires=Sun, 20-Aug-2017 04:00:00 GMT; path=/
Set-Cookie AWSELB=3F3161E706F6390F619F0941EA19F524DED25A2DE4D86AD6FB1A2BC237ABEF60079B9733E292693FE01C167AA13F2F5099BB72633CEE5E3B2FDB866C3B00533AE94D492E87;PATH=/;MAX-AGE=86400
Vary Accept-Encoding
X-AspNet-Version 4.0.30319
X-AspNetMvc-Version 4.0
X-Powered-By ASP.NET
Content-Length 35766
Connection keep-alive

Meta Tags

title="Cancer Articles, News & Research Info | Treatment & Drug Trials - Cancer Therapy Advisor"
name="viewport" content="width=device-width, initial-scale=1.0"
name="Content-Type" content="text/html"
name="content-language" content="en-US"
name="description" content="Latest cancer articles, treatment info, research news and more for oncologists and other medical professionals. Updated cancer news delivered to your inbox."
name="ROBOTS" content="INDEX,FOLLOW"
name="apple-itunes-app" content="app-id=587577694"
property="fb:app_id" content="384307355013443"
name="google-site-verification" content="44ZDMWtYdt2P3WmcSwkf49lSAsp6XFIm2_f77bM61lc"
name="msvalidate.01" content="956DD126339184D52366A23FB24399F3"
name="msvalidate.01" content="1EBAD585CD1400AF57A0E16F3A19B4E3"
name="com.silverpop.brandeddomains" content="www.pages05.net,cancertherapyadvisor.com,chemotherapyadvisor.com,clinicaladvisor.com,empr.com,mycme.com,oncologynurseadvisor.com,psychiatryadvisor.com,renalandurologynews.com"

Load Info

page size158044
load time (s)0.485604
redirect count1
speed download73652
server IP54.236.152.82
* all occurrences of the string "http://" have been changed to "htt???/"